1. Home
  2. MLYS vs SPSC Comparison

MLYS vs SPSC Comparison

Compare MLYS & SPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$30.19

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo SPS Commerce Inc.

SPSC

SPS Commerce Inc.

HOLD

Current Price

$53.37

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLYS
SPSC
Founded
2019
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
2023
2009

Fundamental Metrics

Financial Performance
Metric
MLYS
SPSC
Price
$30.19
$53.37
Analyst Decision
Strong Buy
Hold
Analyst Count
7
10
Target Price
$48.67
$96.80
AVG Volume (30 Days)
1.1M
463.8K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
37.43
20.59
EPS
N/A
0.53
Revenue
N/A
$220,566,000.00
Revenue This Year
N/A
$8.85
Revenue Next Year
N/A
$7.37
P/E Ratio
N/A
$101.04
Revenue Growth
N/A
14.11
52 Week Low
$12.59
$49.04
52 Week High
$47.65
$147.61

Technical Indicators

Market Signals
Indicator
MLYS
SPSC
Relative Strength Index (RSI) 59.06 46.10
Support Level $25.88 $52.67
Resistance Level $31.12 $55.00
Average True Range (ATR) 1.45 2.33
MACD 0.22 0.16
Stochastic Oscillator 91.67 43.78

Price Performance

Historical Comparison
MLYS
SPSC

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

About SPSC SPS Commerce Inc.

SPS Commerce Inc is a provider of cloud-based supply chain management services for retailers, grocers, distributors, suppliers, and logistics firms to increase supply chain performance, optimize inventory levels and sell-through, reduce operational costs, improve order visibility, and satisfy consumer demands for a seamless omnichannel experience. Its solutions are delivered through the SPS Commerce platform and provide integrations and retail performance analytics to its customers. The company has one operating segment Supply Chain Management Solutions, that derives revenues from customers by providing access to cloud-based supply chain management services, primarily under subscription-based service arrangements.

Share on Social Networks: